Related Experiment Video
Updated: Sep 6, 2025

09:45
Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology
Published on: February 25, 2019
35.7K
Traditional protocols and optimization methods lead to absent expression in a mycoplasma cell-free gene expression
Andrei Sakai, Christopher R Deich1, Frank H T Nelissen2
1Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
Synthetic Biology (Oxford, England)
|July 1, 2022
Summary
Researchers aimed to create a Mycoplasma-based cell-free expression (CFE) system but found high ribonuclease activity in lysates, preventing gene expression. This study highlights challenges in developing novel CFE systems for synthetic biology applications.
Area of Science:
- Synthetic biology
- Microbiology
Background:
- Cell-free expression (CFE) systems are crucial for synthetic cell development.
- Orthogonality of CFE systems across different species remains a significant challenge.
- Genome-minimized bacteria like JCVI-syn3A offer potential platforms for novel CFE systems.
Purpose of the Study:
- To optimize a Mycoplasma bacterium-based CFE system using lysates from JCVI-syn3A and Mycoplasma capricolum.
- To overcome species-specific limitations in existing CFE platforms.
- To establish a compatible CFE system for minimal cell constructs.
Main Methods:
- Systematic testing of bacterial lysate production methods based on the Escherichia coli S30 protocol.
- Optimization of lysate production and feeding buffer composition.
- Investigation of ribonuclease (RNase) activity and alternative lysate preparation using digitonin.
Main Results:
- Mycoplasma capricolum and JCVI-syn3A lysates did not support cell-free gene expression.
- Only minimal in vitro transcription of RNA aptamers was observed.
- High ribonuclease activity was consistently detected in all tested lysates, degrading ribosomal RNAs and inhibiting CFE.
Conclusions:
- Developing Mycoplasma-based CFE systems is hindered by persistent, high ribonuclease activity.
- Surface-associated RNase activity in Mycoplasma cells, including minimal variants, poses a significant barrier.
- This research serves as a cautionary account for future efforts in creating novel CFE systems from Mycoplasma.

